Alto Neuroscience, Inc. — Form 4
Filed October 1, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 54/100
What the filing says
PRESIDENT AND CFO Smith Nicholas Conrad (ANRO) sold 270K shares (~$3.6M) on the open market (69% of holdings). Large sale — ~69% of holdings.
Why this rating
Large sale — ~69% of holdings.
See more from October 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.